Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's national immunization program

Clinical Infectious Diseases

Volumn 57, Issue 10, 2013, Pages 1427-1434

  Carlin, John B ^a,b   Macartney, Kristine K ^e,f   Lee, Katherine J ^a,b   Quinn, Helen E ^e   Buttery, Jim ^a,c,d   Lopert, Ruth ^g   Bines, Julie ^a,b   McIntyre, Peter B ^e,f  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH CHILDREN S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^g THERAPEUTIC GOODS ADMINISTRATION   (Australia)

Author keywords

Intussusception; Rotavirus vaccine; Vaccination risk benefit; Vaccine adverse events; Vaccine surveillance

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CONTROLLED STUDY; GASTROENTERITIS; HOSPITALIZATION; HUMAN; INFANT; INTUSSUSCEPTION; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SELF CONTROL; TREATMENT DURATION; VACCINATION;

INTUSSUSCEPTION; ROTAVIRUS VACCINE; VACCINATION RISK-BENEFIT; VACCINE ADVERSE EVENTS; VACCINE SURVEILLANCE;

AUSTRALIA; CASE-CONTROL STUDIES; HUMANS; INFANT; INTUSSUSCEPTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84884928213     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit520     Document Type: Article

References (37)

1. Fischer Walker C.L., Rudan I, Liu L., et al Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381: 1405-16.
2. Tate JE, Burton AH, Boschi-Pinto C, et al Estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet 2012; 12: 136-41.
3. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48: 1007.
4. World Health Organization. Rotavirus vaccines WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88: 49-64.
5. Justice F, Carlin J, Bines J. Changing epidemiology of intussusception in Australia. J Paediatr Child Health 2005; 41: 475-8.
6. Ruiz-Palacios G., Pérez-Schael I, Velázquez F, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
7. Vesikari T, Matson DO, Dennehy P, et al Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
8. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84: 553-40.
9. Gurgel RQ, Ilozue C, Correia J.B., Centenari C., Oliveira SMT, Cuevas LE Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health 2011; 16: 1180-4.
10. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362: 299-305.
11. Anderson E, Shippee D, Weinrobe M., et al Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis 2013; 56: 755-60.
12. Buttery JP, Lambert SB, Grimwood K, et al Reduction in rotavirus-as-sociated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30: 916.
13. Curns A, Steiner C, Barrett M., Hunter K, Wilson E, Parashar U. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201: 1617-24.
14. Desai R, Curns A, Steiner C., Tate J, Patel M, Parashar U. All-cause gastroenteritis and rotavirus-coded hospitalizations among US Children, 2000-2009. Clin Infect Dis 2012; 55: e28-34.
15. Quintanar-Solares M., Yen C, Richardson V., Esparza-Aguilar M, Parashar U, Patel M. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 2011; 2011(1 Suppl): S11-S15.
16. Raes M, Strens D, Vergison A., Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30: e120-5.
17. Safadi M, Berezin E, Munford V., et al Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil. Pediatr Infect Dis J 2010; 29: 1019-22.
18. Yen C, Armero Guardado J, Alberto P, et al Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(1 Suppl): S6-10.
19. Macartney KK, Porwal M, Dalton D., et al Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. J Paediatr Child Health 2011; 47: 266-70.
20. Haber P, Patel M, Izurieta H.S., et al Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008; 121: 1206-12.
21. Shui I, Baggs J, Patel M., et al Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307: 598-604.
22. Zickafoose JS, Benneyworth BD, Riebschleger M.P., Davis MM Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med 2012; 166: 350-5.
23. Yen C, Tate JE, Steiner C.A., Cortese MM, Patel MM, Parashar UD Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis 2012; 206: 41-8.
24. Patel M, López-Collada V, Bulhões M, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364: 2283-92.
25. Velazquez FR, Colindres RE, Grajales C, et al Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012; 31: 736-44.
26. Buttery JP, Danchin MH, Lee K.J., et al Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29: 3061-6.
27. Macartney KK, Burgess MA Rapid impact of rotavirus vaccination in the United States: implications for Australia. Med J Aust 2009; 191: 131-2.
28. Bines JE, Kohl KS, Forster J, et al Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22: 569-74.
29. Zurynski Y, McIntyre P, Booy R., Elliot EH; PAEDS Investigators Group. Paediatric Active Enhanced Disease Surveillance: a new surveillance system for Australia. J Paediatr Child Health 2013; 49: 588-94.
30. Hull B, Deeks S, McIntyre P. The Australian Childhood Immunisation Register: a model for universal immunisation registers? Vaccine 2009; 27: 5054-60.
31. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006; 25: 1768-97.
32. National Health and Medical Research Council. The Australian immunisation handbook. 9th ed. Canberra, Australia: Government Department of Health and Ageing, 2008.
33. Murphy T, Gargiullo P, Massoudi M., et al Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344: 564-72.
34. Hull B, Dey A, Mahajan D., Menzies R, McIntyre PB Immunisation coverage annual report, 2009. Commun Dis Intell 2011; 35: 132-48.
35. Hull BP, Menzies R, Macartney K., McIntyre PB Impact of the introduction of rotavirus vaccine on the timelines of other scheduled vaccines: the Australian experience. Vaccine 2013; 31: 1964-9.
36. Macartney KK, Quinn HE, Wood N, et al Human monovalent rotavirus vaccine and intussusception: an increased risk in Australian infants. In: Seventh World Congress of the World Society for Pediatric Infectious Diseases, 16-19 November 2011; Melbourne Australia.
37. Patel MM, Clark AD, Glassa RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009; 27: 2916-22.